4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001562180-18-003561
Options or other derivatives
- President, Diagnostics & Genom acquired 22,768 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kelderman Kim President, Diagnostics & Genom | 2018-08-08 | Grant or award · Restricted Stock Units | +1,691 | 1,691 | D | ||
| Kelderman Kim President, Diagnostics & Genom | 2018-08-08 | Grant or award · Stock Options (Right to buy) | +12,044 | 12,044 | D | ||
| Kelderman Kim President, Diagnostics & Genom | 2018-08-08 | Grant or award · Stock Options (Right to buy) | +9,033 | 9,033 | D | ||
Loading xslF345X03/primarydocument.xml…